Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/44461
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Castro López-Tarruella, Enrique | en_US |
dc.contributor.author | Oset‐Gasque, M. J. | en_US |
dc.contributor.author | Cañadas, S. | en_US |
dc.contributor.author | Gimenez, G. | en_US |
dc.contributor.author | González, M. P. | en_US |
dc.date.accessioned | 2018-11-21T23:15:17Z | - |
dc.date.available | 2018-11-21T23:15:17Z | - |
dc.date.issued | 1988 | en_US |
dc.identifier.issn | 0360-4012 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/44461 | - |
dc.description.abstract | The effect of several ligands and Ca2+ ions on [3H]GABA binding to bovine adrenal medulla membranes was investigated. Without any blockade, the [3H]GABA binding showed two components, one of low affinity (Kd = 139 ± 22 nM and Bmax = 3.2 ± 0.4 pmol/mg protein) and the other of high affinity (Kd = 41 ± 6 nM and Bmax = 0.35 ± 0.26 pmol/mg protein). Muscimol specifically blocked low‐affinity sites, and ( – )baclofen blocked high‐affinity components. Ca2+ ions were strictly necessary for maximum binding to high‐affinity sites, whereas they did not significantly affect sites of the lower affinity. These results show that the bovine adrenal medulla has a GABAA receptor population of low affinity together with a GABAB receptor of high affinity. | en_US |
dc.language | eng | en_US |
dc.publisher | 0360-4012 | |
dc.relation.ispartof | Journal of Neuroscience Research | en_US |
dc.source | Journal of Neuroscience Research [ISSN 0360-4012], v. 20, p. 241-245 | en_US |
dc.subject | 320502 Endocrinología | en_US |
dc.subject | 240104 Citología animal | en_US |
dc.subject | 241003 Citología humana | en_US |
dc.subject.other | GABA receptor | en_US |
dc.subject.other | Adrenal medulla | en_US |
dc.title | GABAA and GABAB sites in bovine adrenal medulla membranes | en_US |
dc.type | info:eu-repo/semantics/article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1002/jnr.490200213 | en_US |
dc.identifier.scopus | 0023821306 | - |
dc.contributor.authorscopusid | 35095882100 | - |
dc.contributor.authorscopusid | 7004173468 | - |
dc.contributor.authorscopusid | 6504022975 | - |
dc.contributor.authorscopusid | 36764277300 | - |
dc.contributor.authorscopusid | 7404553950 | - |
dc.description.lastpage | 245 | - |
dc.description.firstpage | 241 | - |
dc.relation.volume | 20 | - |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.ulpgc | Sí | es |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.fullName | Castro López-Tarruella, Enrique | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
23
checked on Dec 15, 2024
WEB OF SCIENCETM
Citations
22
checked on Dec 15, 2024
Page view(s)
57
checked on May 4, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.